Biopaws IVS — Credit Rating and Financial Key Figures

Biopaws IVS (CVR number: 38407821) is a company from MIDDELFART. The company reported a net sales of 0.5 mDKK in 2018, demonstrating a growth of 30.6 % compared to the previous year. The operating profit percentage was poor at -4.7 % (EBIT: -0 mDKK), while net earnings were -25.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was -62.1 %, which can be considered poor and Return on Equity (ROE) was -117 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 27 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Biopaws IVS's liquidity measured by quick ratio was 1.1 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.